» Articles » PMID: 20049741

Neurodegenerative Diseases: Lessons from Genome-wide Screens in Small Model Organisms

Overview
Journal EMBO Mol Med
Specialty Molecular Biology
Date 2010 Jan 6
PMID 20049741
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Various age-related neurodegenerative diseases, including Parkinson's disease, polyglutamine expansion diseases and Alzheimer's disease, are associated with the accumulation of misfolded proteins in aggregates in the brain. How and why these proteins form aggregates and cause disease is still poorly understood. Small model organisms--the baker's yeast Saccharomyces cerevisiae, the nematode worm Caenorhabditis elegans and the fruit fly Drosophila melanogaster--have been used to model these diseases and high-throughput genetic screens using these models have led to the identification of a large number of genes that modify aggregation and toxicity of the disease proteins. In this review, we revisit these models and provide a comprehensive comparison of the genetic screens performed so far. Our integrative analysis highlights alterations of a wide variety of basic cellular processes. Not all disease proteins are influenced by alterations in the same cellular processes and despite the unifying theme of protein misfolding and aggregation, the pathology of each of the age-related misfolding disorders can be induced or influenced by a disease-protein-specific subset of molecular processes.

Citing Articles

A multi-layered network model identifies Akt1 as a common modulator of neurodegeneration.

Na D, Lim D, Hong J, Lee H, Cho D, Yu M Mol Syst Biol. 2023; 19(12):e11801.

PMID: 37984409 PMC: 10698508. DOI: 10.15252/msb.202311801.


Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective.

Li X, Quan M, Wei Y, Wang W, Xu L, Wang Q Sci China Life Sci. 2023; 66(12):2711-2754.

PMID: 37480469 DOI: 10.1007/s11427-022-2357-x.


Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases.

Gimenez V, de Las Heras N, Lahera V, Tresguerres J, Reiter R, Manucha W Front Aging Neurosci. 2022; 14:888292.

PMID: 35721030 PMC: 9204094. DOI: 10.3389/fnagi.2022.888292.


Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases.

Evans J, Mendonca P, Soliman K Nutrients. 2022; 14(11).

PMID: 35684025 PMC: 9183194. DOI: 10.3390/nu14112228.


Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases.

Dhahri M, Alghrably M, Mohammed H, Badshah S, Noreen N, Mouffouk F Pharmaceutics. 2022; 14(1).

PMID: 35056897 PMC: 8777698. DOI: 10.3390/pharmaceutics14010001.


References
1.
Gaczynska M, Osmulski P, Ward W . Caretaker or undertaker? The role of the proteasome in aging. Mech Ageing Dev. 2001; 122(3):235-54. DOI: 10.1016/s0047-6374(00)00246-3. View

2.
Outeiro T, Kontopoulos E, Altmann S, Kufareva I, Strathearn K, Amore A . Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science. 2007; 317(5837):516-9. DOI: 10.1126/science.1143780. View

3.
van Ham T, Thijssen K, Breitling R, Hofstra R, Plasterk R, Nollen E . C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 2008; 4(3):e1000027. PMC: 2265412. DOI: 10.1371/journal.pgen.1000027. View

4.
Kaeberlein M, McVey M, Guarente L . The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999; 13(19):2570-80. PMC: 317077. DOI: 10.1101/gad.13.19.2570. View

5.
Clancy D, Gems D, Harshman L, Oldham S, Stocker H, Hafen E . Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science. 2001; 292(5514):104-6. DOI: 10.1126/science.1057991. View